Gyre Therapeutics, Inc. (GYRE) — SC 13D Filings
All SC 13D filings from Gyre Therapeutics, Inc.. Browse 1 Activist Stake Filing reports with AI-powered summaries and risk analysis.
SC 13D Filings (1)
-
Luo Ying Files 13D for Gyre Therapeutics
— Sep 6, 2024 Risk: medium
On September 6, 2024, Luo Ying filed a Schedule 13D for Gyre Therapeutics, Inc. (formerly Catalyst Bioscience, Inc. and Targacept Inc.). The filing indicates a
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX